Brief: Medicure says has initiated development of high-value cardiovascular generic drug

Medicure

06/01/2016 13:03

Jan 6 (Reuters) - Medicure Inc  MPH.V : 
 * Says has initiated the development of a high-value cardiovascular generic 
   drug 
 * Project is a collaboration between Medicure International Inc and apicore US 
   llc 
 * Co and apicore have entered into an exclusive product supply and development 
   agreement under which Medicure holds all commercial rights 
 * Says companies anticipate filing the anda with the U.S. food and drug 
   administration by the end of 2016 
 
 * Source text for Eikon  ID:nCNWZx2Xqa  
 * Further company coverage  MPH.V  
 ((Bengaluru Newsroom; +1 646 223 8780))